Chase AIPricingFAQs
Display currency
Loading news…

NuMedii

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Menlo Park, California, United States Founded 2008 11-50 employees For Profit

NuMedii is a biotechnology company that discovers and de-risks effective drugs by translating life sciences big data into therapies.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
3

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private
Valuation range
$10M to $50M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
Active products
10
IT spend
$162K

Company Info

Founded
2008
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
3
News articles
20
HQ
Menlo Park, California, United States
Region
San Francisco Bay Area, Silicon Valley, West Coast
Diversity spotlight
Women Founded; Women Led

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
-0.3
Trend (90d)
-0.5

Key People at NuMedii

Founder and Chief Executive Officer
Chief Financial Officer
3
professional contacts at NuMedii
Contact execs at NuMedii

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to NuMedii

Loading news…

FAQs about NuMedii

People who checked this page also checked these

Browse the full Acquirezy directory.
NuMedii - Company Profile, Full Acquisitions List, Funding and Investments